Literature DB >> 14760404

US soldiers refuse to fall in line with anthrax vaccination scheme.

Tinker Ready.   

Abstract

Entities:  

Keywords:  Health Care and Public Health; Legal Approach

Mesh:

Substances:

Year:  2004        PMID: 14760404     DOI: 10.1038/nm0204-112b

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine.

Authors:  Hang Xie; Ihsan Gursel; Bruce E Ivins; Manmohan Singh; Derek T O'Hagan; Jeffrey B Ulmer; Dennis M Klinman
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.

Authors:  Karina Ramirez; Yanina Ditamo; James E Galen; Les W J Baillie; Marcela F Pasetti
Journal:  Vaccine       Date:  2010-07-07       Impact factor: 3.641

Review 3.  The social, political, ethical, and economic aspects of biodefense vaccines.

Authors:  Gregory A Poland; Robert M Jacobson; Jon Tilburt; Kristin Nichol
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

4.  Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax.

Authors:  Dennis M Klinman; Debra Currie; Gloria Lee; Vanessa Grippe; Tod Merkel
Journal:  Microbes Infect       Date:  2007-08-10       Impact factor: 2.700

5.  Effect of CpG oligonucleotides on vaccine-induced B cell memory.

Authors:  Debra Tross; Dennis M Klinman
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

Review 6.  Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

Authors:  Julia Scheiermann; Dennis M Klinman
Journal:  Vaccine       Date:  2014-06-24       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.